Company: KVACU
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001213900-25-109170
Chunk: 70

Company: Keen Vision Acquisition Corp.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 8
Chunk 70
---
 is currently not aware of any issues under review that could result in significant payments, accruals or material deviation
from its position.

The Company may be subject to potential examination
by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount
of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company’s management
does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. As such, the Company’s
tax provision was zero for the periods presented.

The Company is considered to be an exempted British
Virgin Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax
filing requirements in the British Virgin Islands.

After the Initial Public Offering, the proceeds
held in the Trust Account will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money
market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury
obligations. An investment in this offering may result in uncertain U.S. federal income tax consequences.

13

●Net
income (loss) per share

The Company calculates net income (loss) per share
in accordance with ASC Topic 260, Earnings per Share. In order to determine the net income (loss) attributable to both the redeemable
shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable ordinary
shares and non-redeemable ordinary shares and the undistributed income (loss) is calculated using the total net income (loss) less any
dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding
between the redeemable and non-redeemable ordinary shares. Any remeasurement of the accretion to the redemption value of the ordinary
shares subject to possible redemption was considered to be dividends paid to the public stockholders. Accretion associated with the redeemable
shares of ordinary share is excluded from earnings per share as the redemption value approximates fair value. As of September 30, 2025
and December 31, 2024, the Company has not considered the effect of the warrants sold in the Initial Public Offering and private warrants
to purchase an aggregate of 15,628,